Lippia multiflora

Lippia multiflora contains active compounds such as thymol, carvacrol, and linalool which exhibit antipyretic and antimicrobial properties. These volatile oils are thought to work by modulating inflammatory pathways and disrupting microbial cell membranes. While the exact mechanism requires further study, these actions support its traditional use in managing fevers and infections (Evidence Level C).

Lippia multiflora is considered unsafe during pregnancy, particularly at therapeutic doses. The herb contains volatile oils that may stimulate uterine contractions or pose risks to fetal development. Women who are pregnant or breastfeeding should avoid consuming Lippia multiflora tea or supplements due to these potential risks and lack of safety data.

The standard adult dosage for Lippia multiflora is 5 to 10 grams of dried leaves prepared as an infusion (tea). This amount is traditionally used for managing fever and headache. Due to limited clinical safety data, usage should be restricted to short-term application, and individuals should adhere to recommended amounts to avoid potential side effects.

While specific clinical interaction studies are lacking, Lippia multiflora contains compounds like thymol that may affect liver enzyme activity. Theoretically, this could alter the metabolism of antimalarial medications or other drugs processed by the liver. Patients undergoing malaria treatment should consult a healthcare provider before using this herb to ensure therapeutic efficacy is not compromised.

Lippia multiflora is generally well-tolerated when used in traditional doses, but some individuals may experience mild gastrointestinal upset. Due to the presence of volatile oils, excessive consumption may increase the risk of adverse reactions. Users should monitor for digestive discomfort and discontinue use if symptoms persist or worsen.